CA3238997A1 - Compositions and methods for detection of ovarian cancer - Google Patents
Compositions and methods for detection of ovarian cancer Download PDFInfo
- Publication number
- CA3238997A1 CA3238997A1 CA3238997A CA3238997A CA3238997A1 CA 3238997 A1 CA3238997 A1 CA 3238997A1 CA 3238997 A CA3238997 A CA 3238997A CA 3238997 A CA3238997 A CA 3238997A CA 3238997 A1 CA3238997 A1 CA 3238997A1
- Authority
- CA
- Canada
- Prior art keywords
- biomarker
- target
- polypeptide encoded
- human gene
- antigen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6804—Nucleic acid analysis using immunogens
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
- C12Q1/6853—Nucleic acid amplification reactions using modified primers or templates
- C12Q1/6855—Ligating adaptors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
- G01N33/54326—Magnetic particles
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57545—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the ovaries
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Analytical Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- Pathology (AREA)
- Biochemistry (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Genetics & Genomics (AREA)
- General Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Food Science & Technology (AREA)
- Cell Biology (AREA)
- Medicinal Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hospice & Palliative Care (AREA)
- Oncology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163280603P | 2021-11-17 | 2021-11-17 | |
| US63/280,603 | 2021-11-17 | ||
| US202263328250P | 2022-04-06 | 2022-04-06 | |
| US63/328,250 | 2022-04-06 | ||
| US202263417309P | 2022-10-18 | 2022-10-18 | |
| US63/417,309 | 2022-10-18 | ||
| PCT/US2022/050327 WO2023091618A1 (en) | 2021-11-17 | 2022-11-17 | Compositions and methods for detection of ovarian cancer |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA3238997A1 true CA3238997A1 (en) | 2023-05-25 |
Family
ID=86397740
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA3238997A Pending CA3238997A1 (en) | 2021-11-17 | 2022-11-17 | Compositions and methods for detection of ovarian cancer |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20250327129A1 (enExample) |
| EP (1) | EP4433827A4 (enExample) |
| JP (1) | JP2024543085A (enExample) |
| CA (1) | CA3238997A1 (enExample) |
| WO (1) | WO2023091618A1 (enExample) |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20140271453A1 (en) * | 2013-03-14 | 2014-09-18 | Abbott Laboratories | Methods for the early detection of lung cancer |
| CN113748217B (zh) * | 2019-03-01 | 2023-08-25 | 仁慈生物分析公司 | 用于靶实体检测的系统、组合物和方法 |
| US20230243834A1 (en) * | 2020-01-17 | 2023-08-03 | Mercy Bioanalytics, Inc. | Compositions and methods for detection of ovarian cancer |
-
2022
- 2022-11-17 JP JP2024529398A patent/JP2024543085A/ja active Pending
- 2022-11-17 EP EP22896502.6A patent/EP4433827A4/en active Pending
- 2022-11-17 WO PCT/US2022/050327 patent/WO2023091618A1/en not_active Ceased
- 2022-11-17 CA CA3238997A patent/CA3238997A1/en active Pending
- 2022-11-17 US US18/710,728 patent/US20250327129A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| JP2024543085A (ja) | 2024-11-19 |
| US20250327129A1 (en) | 2025-10-23 |
| WO2023091618A1 (en) | 2023-05-25 |
| EP4433827A4 (en) | 2026-01-14 |
| EP4433827A1 (en) | 2024-09-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP3931351B1 (en) | Method for target entity detection using ligase | |
| US20230243834A1 (en) | Compositions and methods for detection of ovarian cancer | |
| CA3227133A1 (en) | Compositions and methods for cancer detection | |
| WO2023004083A2 (en) | Compositions and methods for detection of bile duct cancer | |
| WO2023004079A2 (en) | Compositions and methods for detection of liver cancer | |
| US20250043357A1 (en) | Compositions and methods for detection of esophageal cancer | |
| JP2024529386A (ja) | 前立腺がんの検出のための組成物および方法 | |
| US20240369558A1 (en) | Compositions and methods for detection of breast cancer | |
| US20240369560A1 (en) | Compositions and methods for detection of pancreatic cancer | |
| US20240344139A1 (en) | Compositions and methods for detection of colorectal cancer | |
| US20250327129A1 (en) | Compositions and methods for detection of ovarian cancer | |
| HK40076883A (en) | Compositions and methods for target protein detection on exosomes using proximal ligation | |
| HK40066670A (en) | Method for target entity detection using ligase | |
| HK40066670B (en) | Method for target entity detection using ligase |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MFA | Maintenance fee for application paid |
Free format text: FEE DESCRIPTION TEXT: MF (APPLICATION, 2ND ANNIV.) - STANDARD Year of fee payment: 2 |
|
| U00 | Fee paid |
Free format text: ST27 STATUS EVENT CODE: A-1-1-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED Effective date: 20240930 |
|
| U11 | Full renewal or maintenance fee paid |
Free format text: ST27 STATUS EVENT CODE: A-1-1-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL Effective date: 20240930 |
|
| MFA | Maintenance fee for application paid |
Free format text: FEE DESCRIPTION TEXT: MF (APPLICATION, 3RD ANNIV.) - STANDARD Year of fee payment: 3 |
|
| U00 | Fee paid |
Free format text: ST27 STATUS EVENT CODE: A-1-1-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED Effective date: 20250923 |
|
| U11 | Full renewal or maintenance fee paid |
Free format text: ST27 STATUS EVENT CODE: A-1-1-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL Effective date: 20250923 |